Phase 1 Parkinsons Disease Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)

Parkinsons Disease

Regeneron Pharmaceuticals46 enrolled2 locationsNCT07216066

Recruiting

Phase 1

Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.

Parkinsons Disease (PD)

Pravat Mandal12 enrolled1 locationNCT07064005

Recruiting

Phase 1

Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies

Multiple System AtrophyParkinsons Disease

Craig van Horne, MD, PhD7 enrolled1 locationNCT06683365